Drugs / DTPa-IPV/Hib
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01457495 Comparator | Sep 1998 → Sep 1999 | diphtheria, haemophilus meningitis, hepatitis B virus infection, pertussis +2 | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTPa-IPV/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01457495 ↗ |
| Known as | Infanrix-IPV/Hib | “DTPa-IPV/Hib (Infanrix-IPV/Hib™)” NCT01457495 ↗ |